Abstract
Efficient expansion of hematopoietic progenitor cells requires, at least, the simultaneous stimulation of the receptors c-kit and gp130. While c-kit is activated by SCF; gp130, in cells which do not express sufficient amounts of IL-6R, can be activated by the complex of soluble IL-6R (slL-6R) and IL-6. The therapeutic use of IL-6/sIL-6R, however, has been hampered by the high concentrations of the sIL-6R protein required. We have designed a fusion protein of sIL-6R and IL-6, linked by a flexible peptide chain, that was expressed to high levels. On gp130 expressing cells the fusion protein turned out to be fully active at 100 to 1,000-fold lower concentration than the combination of unlinked IL-6 and IL-6R. The fusion protein was used to effectively expand human hematopoietic progenitor cells ex vivo in a dose dependent fashion.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Human brain organoid model of maternal immune activation identifies radial glia cells as selectively vulnerable
Molecular Psychiatry Open Access 06 March 2023
-
The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
Molecular Neurodegeneration Open Access 21 February 2023
-
Generation and characterization of a Müller-glial-cell-specific Il6ra knockout mouse to delineate the effects of IL-6 trans-signaling in the retina
Scientific Reports Open Access 21 October 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Mackiewicz, A., Koj, A., and Sehgal, P.B. . 1995. Interleukin-6-Type Cytokines. Proc. N. Y. Acad. Sci 762: 1–522.
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., and Kishimoto, T. 1988. Cloning and expression of the human interleukin-6 (BSF-2/IFN β2) receptor. Science 241: 825–828.
Davis, S., Aldrich, T.H., Valenzuela, D.M., Wong, V., Furth, M.E., Squinto, S.P., Yancopoulous, G.D., 1991. Receptor for Ciliary Neurotrophic Factor. Science 253: 59–63.
Hilton, D.J., Hilton, A.A., Raicevic, A., Rakar, S., Harrison-Smith, M., Gough, N.M., Begley, C.G., Metcalf, D., Nicola, N.A., and Willson, T.A. 1994. Cloning of a murine IL-11 receptor α-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 13: 4765–4775.
Sui, X., Tsuji, K., Tanaka, R., Tajima, S., Muraoka, K., Ebihara, Y., Ikebuchi, K., Yasukawa, K., Taga, T., Kishimoto, T. and Nakahata, T. 1995. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc. Natl. Acad. Sci. USA 92: 2859–2863.
Kishimoto, T., Taga, T., and Akira, S. 1994. Cytokine signal transduction. Cell 76: 253–262.
Rose-John, S. and Heinrich, P.C. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300: 281–290.
Hirota, H., Kiyama, H., Kishimoto, T., and Taga, T., 1996. Accelerated Nerve Regeneration in Mice by upregulated expression of Interleukin (IL) 6 and IL-6 Receptor. J. Exp Med 183: 2627–2634.
Rose-John, S., Schooltink, H., Lenz, D., Hipp, E., Dufhues, G., Schmitz, H., Schiel, X., Hirano, T., Kishimoto, T., and Heinrich, P.C. 1990. Studies on the structure and regulation of the human hepatic interleukin-6-recep-tor. Eur. J. Biochem. 190: 79–83.
Wells, J.A. Binding in the growth hormone receptor complex. 1996. Proc. Natl. Acad. Sci. USA 93: 1–6.
Toniatti, C., Cabibbo, A., Sporeno, E., Salvati, A.L., Cerretani, M., Serafini, S., Lahm, A., Cortese, R., and Ciliberto, G. 1996. EMBO J. 15: 2726–2737.
Grötzinger, J., Kurapkat, G., Wollmer, A., Kalai, M., and Rose-John, S. 1996. The family of the IL-6-type cytokines: Specificity and Promiscuity of the Receptor Complexes. Proteins, in press.
De Vos, A.M., Ultsch, M., and Kossiakoff, A.A. 1992. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255: 306–312.
Bird, R.E., Hardman, K.D., Jacobson, J.W., Johnson, S., Kaufman, B.M., Lee, S.M., Lee, T., Pope, S.H., Riordan, G.S. and Whitlow, M. 1988. Single-chain antigen-binding proteins. Science 423: 423–426.
Huston, J.S., Levinson, D., Mudgett-Hunter, M., Tai, M.S., Novotny, J., Margolies, M.N., Ridge, R.J., Bruccoleri, R.E., Haber, E., Crea, R. and Oppermann, H. 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85: 5879–5883.
Yawata, H., Yasukawa, K., Natsuka, S., Murakami, M., Yamasaki, K., Hibi, M., Taga, T., and Kishimoto, T. 1993. Structure-function analysis of the human IL-6 receptor: dissociation of amino acid residues required for IL-6 binding and for IL-6 signal transduction through gp 130. EMBO J. 12: 1705–1712.
Yasukawa, K., Saito, T., Fukunaga, T., Sekimori, Y., Koishihara, Y., Fukui, H., Ohsugi, Y., Matsuda, T., Yawata, H., Hirano, T., Taga, T., and Kishimoto, T. 1990. Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J. Biochem. 108: 673–676.
Vollmer, P., Peters, M., Ehlers, M., Yagame, H., Matsuba, T., Kondo, M., Yasukawa, K. Meyer zum Büschenfelde, K.H., and Rose-John, S., 1996. Yeast Expression of the Cytokine Receptor Domain of the Soluble Interleukin-6-Receptor. J. Immunol. Meth., 199: 47–54.
Brakenhoff, J.P.J., Hart, M., de Groot, E.R., Di Padova, F., and Aarden, L.A., 1990. Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxy-terminal deletion mutants. J. Immunol. 145: 561–568.
Gearing, D.P., Ziegler, S.F., Comeau, M.R., Friend, D., Thoma, B., Cosman, D., Park, L., and Mosley, B. 1994. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proc. Natl. Acad. Sci. USA 91: 1119–1123.
Tajima, S., Tsuji, K., Ebihara, Y., Sui, X., Tanaka, R., Muraoka, K., Yoshida, M., Yamada, K., Yasukawa, K., Taga, T., Kishimoto, T., and Nakahata, T. 1996. Analysis of Interleukin-6 Receptor and gp 130 Expressions and Proliferative Capability of Human CD34+ Cells. J. Exp. Med. 184: 1357–1364.
Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., Kariyone, S., Hirano, T., Kishimoto, T., Takatsuki, F., Akiyama, Y. 1989. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74: 1241–1244.
Porgador, A., Tzehoval, E., Katz, A., Vadai, E., Revel, M., Feldman, M. and Eisenbach, L. 1992. Interleukin-6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res 52: 3679–3686.
Treanor, J.J.S., Goodman, L., de Sauvage, F., Stone, D.M., Poulsen, K.T., Beck, C.D., Gray, C., Armanini, M.P., Pollock, R.A., Hefti, F., Phillips, H.S., Goddard, A., Moore, M.W., Buj-Bello, A., Davies, A.M., Asai, N., Takahashi, M., Vandlen, R., Henderson, C.E., and Rosenthal, A. 1996. Characterization of a multicomponent receptor for GDNF. Nature 382: 80–83.
Krüttgen, A., Rose-John, S., Möller, C., Wroblowski, B., Wollmer, A., Müllberg, J., Hirano, T., Kishimoto, T., and Heinrich, P.C. 1990. Structure-function analysis of human interleukin-6. Evidence for the involvement of the carboxy-terminus in function. FEBS Lett. 262: 323–326.
Oppmann, B., Stoyan, T., Vollmer, P., Voltz, N., Fischer, M., and Rose-John, S. 1996. A convenient assay for different species of cytokines and soluble receptors of the IL-6 type cytokine family. J. Immunol. Meth. 195: 153–159.
Van Dam, M., Müllberg, J., Schooltink, H., Stoyan, T., Brakenhoff, J., Heinrich, P.C., and Rose-John, S. 1993. Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules: involvement of two separate domains in receptor binding. J. Biol. Chem. 268: 15285–15290.
Ehlers, M., Grötzinger, A., De Hon, F.D., Brakenhoff, J.P.J., Liu, J., Wollmer, A., and Rose-John, S. 1994. Identification of two novel regions of Interleukin-6 involved in receptor binding and signal transduction. J. Immunol. 153: 1755–1764.
Keller, U., Aman, M.J., Derigs, G., Huber, C., Peschel, C. 1994. Human interleukin-4 enhances stromal cell-dependent hematopoiesis: costimulation with stem cell factor. Blood 84: 2189–2196.
Carson, M. 1991. Ribbons 2.0. J. Appl. Cryst. 24: 946–950.
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S., Nakajima, K., Koyoma, K., Iwamatu, A., Tsunasawa, S., Sakiyama, F., Matsui, H., Takahara, Y., Taniguchi, T. and Kishimoto, T. 1986. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73–76.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fischer, M., Goldschmitt, J., Peschel, C. et al. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 15, 142–145 (1997). https://doi.org/10.1038/nbt0297-142
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0297-142
This article is cited by
-
The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
Molecular Neurodegeneration (2023)
-
Human brain organoid model of maternal immune activation identifies radial glia cells as selectively vulnerable
Molecular Psychiatry (2023)
-
Strawberry notch homolog 2 regulates the response to interleukin-6 in the central nervous system
Journal of Neuroinflammation (2022)
-
Lasso-grafted designer cytokines
Nature Biomedical Engineering (2022)
-
Generation and characterization of a Müller-glial-cell-specific Il6ra knockout mouse to delineate the effects of IL-6 trans-signaling in the retina
Scientific Reports (2022)